This inventor holds 2 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignees: Laboratoire Hra-Pharma, Other. Active years: 2013-2017.
Company Filing History:
Years Active: 2013-2017
Title: Florian Battung: Innovator in Pharmaceutical Compositions
Introduction
Florian Battung is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems and formulations. With a total of 2 patents, his work focuses on enhancing the bioavailability and therapeutic applications of various compounds.
Latest Patents
One of his latest patents is a co-micronization product comprising ulipristal acetate. This invention involves a co-micronization product that includes an active ingredient selected from ulipristal acetate, its metabolites, and mixtures thereof, along with a pharmaceutically acceptable solid surfactant. The invention also encompasses a pharmaceutical composition that utilizes this co-micronization product and its therapeutic uses.
Another significant patent is the self-microemulsifying mitotane composition. This invention relates to a self-microemulsifying drug delivery system (SMEDDS) for mitotane, which enhances its bioavailability. The formulation includes propylene glycol monocaprylate, propylene glycol dicaprate, and polyoxyethylenesorbitanne monooleate in specific proportions.
Career Highlights
Florian Battung has worked with Laboratoire Hra-Pharma, where he has contributed to various innovative projects. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Florian has collaborated with notable professionals, including Pierre-Yves Juvin and Jérôme Hecq. These collaborations have further enriched his work and contributed to the advancement of pharmaceutical technologies.
Conclusion
Florian Battung is a distinguished inventor whose work in pharmaceutical compositions has led to innovative solutions in drug delivery systems. His patents reflect a commitment to improving therapeutic outcomes and enhancing the efficacy of medications.